v3.20.4
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating Activities    
Net income (loss) $ 719 $ (1,932)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 325 406
Write-down of inventory 48 311
Deferred income taxes   784
Non-cash share-based compensation expense 65 68
Loss on sale of subsidiary   2,793
Provision for (reversal of) allowance for doubtful accounts, net 5 (59)
Other, net 3 13
Changes in operating assets and liabilities:    
Accounts receivable (2,702) 3,296
Inventories 613 1,025
Other assets 20 (1,458)
Accounts payable 738 (1,983)
Accrued income taxes 34 (1,616)
Accrued and other liabilities 304 (486)
Contract liabilities (68) (1,330)
Net cash provided by (used in) operating activities 104 (168)
Investing Activities    
Purchases of property, plant and equipment (198) (173)
Net cash disposed of in sale of subsidiary   (647)
Net cash used in investing activities (198) (820)
Financing Activities    
Proceeds from the exercise of stock options 135 701
Payments on long-term debt (93) (103)
Net cash provided by financing activities 42 598
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash 596 1,141
Net Increase in Cash, Cash Equivalents and Restricted Cash 544 751
Cash, Cash Equivalents and Restricted Cash, Beginning of Period [1] 45,070 59,134
Cash, Cash Equivalents and Restricted Cash, End of Period [1] $ 45,614 $ 59,885
[1] Includes Cash, Cash Equivalents and Restricted Cash that are included in Held-For-Sale Assets on the Condensed Consolidated Balance Sheets for periods prior to January 22, 2020.

Source